Shares of Balchem Co. (NASDAQ:BCPC - Get Free Report) fell 85.3% during mid-day trading on Friday . The stock traded as low as $166.50 and last traded at $24.46. 7,701 shares changed hands during trading, a decline of 94% from the average session volume of 136,774 shares. The stock had previously closed at $166.50.
Analysts Set New Price Targets
Several research firms have issued reports on BCPC. HC Wainwright reissued a "buy" rating and set a $190.00 target price on shares of Balchem in a research note on Monday, February 24th. Sidoti raised Balchem to a "hold" rating in a research note on Tuesday, February 25th. Finally, StockNews.com cut Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th.
Get Our Latest Research Report on BCPC
Balchem Stock Performance
The firm has a 50-day moving average price of $164.07 and a 200 day moving average price of $169.70. The firm has a market capitalization of $5.42 billion, a PE ratio of 6.23, a price-to-earnings-growth ratio of 4.41 and a beta of 0.63. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19.
Balchem (NASDAQ:BCPC - Get Free Report) last released its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The firm had revenue of $240.00 million for the quarter, compared to analysts' expectations of $239.96 million. Research analysts expect that Balchem Co. will post 4.64 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the company. Westside Investment Management Inc. purchased a new position in shares of Balchem during the third quarter worth $27,000. Covestor Ltd boosted its holdings in Balchem by 93.8% in the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after purchasing an additional 76 shares during the period. R Squared Ltd purchased a new position in Balchem in the fourth quarter valued at $29,000. Wilmington Savings Fund Society FSB purchased a new position in Balchem in the third quarter valued at $35,000. Finally, Federated Hermes Inc. purchased a new position in Balchem in the fourth quarter valued at $33,000. 87.91% of the stock is currently owned by hedge funds and other institutional investors.
Balchem Company Profile
(
Get Free Report)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Read More
Before you consider Balchem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Balchem wasn't on the list.
While Balchem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
